Fenofibrate
Showing 1 - 25 of 218
Safety Study of Fenofibrate During Pregnancy
Recruiting
- Severe Hypertriglyceridemia During Pregnancy
- Fenofibrate
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
May 31, 2023
Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)
Not yet recruiting
- Breast Cancer Stage 2 and 3
- Fenofibrate
- +3 more
- (no location specified)
Nov 24, 2023
Breast Cancer Trial in Damanhur (Placebo, Fenofibrate 160mg)
Recruiting
- Breast Cancer
- Placebo
- Fenofibrate 160mg
-
Damanhūr, Elbehairah, EgyptDamanhour Oncology Center
Apr 1, 2023
Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)
Recruiting
- Primary Biliary Cholangitis
- Fenofibrate 200mg
- +2 more
-
Xi'an, Shaanxi, ChinaXijing Hospital
Mar 3, 2023
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes
Recruiting
- Covid19
- Fenofibrate
- Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 18, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate 160mg
-
Tanta, EgyptTanta Unuversity
Mar 6, 2023
IBD Trial in Tanta (Mesalamine, Fenofibrate)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 11, 2023
Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With
Recruiting
- Primary Biliary Cholangitis
- Placebo Combined With Ursodeoxycholic Acid
- Fenofibrate Combined With Ursodeoxycholic Acid
-
Xi'an, Shaanxi, ChinaYing han
Mar 3, 2023
Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction Trial in Padova (Fenofibrate 145 mg, Placebo)
Recruiting
- Type 2 Diabetes
- +2 more
- Fenofibrate 145 mg
- Placebo
-
Padova, Padua, ItalyUniversity Hospital of Padova
Sep 13, 2022
Liver Transplant Trial in Phoenix (Fenofibrate)
Recruiting
- Liver Transplant
- Fenofibrate
-
Phoenix, ArizonaMayo Clinic Arizona
Aug 23, 2022
Dyslipidemia, Atherosclerosis, Diabetes, Type 2 Trial (Choline fenofibrate, Policosanol)
Recruiting
- Dyslipidemia
- +2 more
- Choline fenofibrate
- Policosanol
-
Seongnam, Gyeonggi, Korea, Republic ofSNUBH
Oct 1, 2022
Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)
Recruiting
- Diabetic Nephropathies
- Fenofibrate
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 15, 2022
Diabetes, Type II Trial in Charleston (Fenofibrate)
Completed
- Diabetes Mellitus, Type II
- Fenofibrate
-
Charleston, South CarolinaMedical University of South Carolina
Jan 11, 2022
Diabetes, Type 2 Trial in Tanta (Glimepiride Tablets, glimepiride plus fenofibrate, glimepiride plus curcumin)
Completed
- Diabetes Mellitus, Type 2
- Glimepiride Tablets
- +2 more
-
Tanta, El-Gharbia, EgyptTanta University Hospital
Feb 16, 2022
Dyslipidemia Associated With Type II Diabetes Trial in Mexico City (Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose,
Recruiting
- Dyslipidemia Associated With Type II Diabetes Mellitus
- Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose
- Atorvastatin (Lipitor ®)
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Aortic Valve Stenosis Trial in Oxford (Fenofibrate Capsules, Placental Lactogen)
Active, not recruiting
- Aortic Valve Stenosis
- Fenofibrate Capsules
- Placental Lactogen
-
Oxford, United KingdomOUH NHS trust
Feb 15, 2022
Hyperbilirubinemia, Neonatal Trial (Fenofibrate Capsules)
Not yet recruiting
- Hyperbilirubinemia, Neonatal
- Fenofibrate Capsules
- (no location specified)
Aug 22, 2021
Corona Virus Disease (COVID-19), Respiratory Distress Syndrome, SARS-CoV-2 Infection Trial in Ashkelon, Haifa, Nazareth (TriCor®
Recruiting
- Corona Virus Disease (COVID-19)
- +2 more
- TriCor® 145mg tablets
- +2 more
-
Ashkelon, Israel
- +2 more
Feb 23, 2022
Klinefelter Syndrome Trial in Aurora (Fenofibrate 145 mg)
Not yet recruiting
- Klinefelter Syndrome
- Fenofibrate 145 mg
-
Aurora, ColoradoUniversity of Colorado - Anschutz Medical Campus
Aug 9, 2022
Primary Biliary Cirrhosis Trial in Beijing (Fenofibrate, UDCA)
Withdrawn
- Primary Biliary Cirrhosis
- Fenofibrate
- UDCA
-
Beijing, ChinaBeijing 302 hospital
Sep 12, 2021
Diabetic Retinopathy Trial in United Kingdom (Fenofibrate 145 mg, Placebo Oral Tablet)
Active, not recruiting
- Diabetic Retinopathy
- Fenofibrate 145 mg
- Placebo Oral Tablet
-
Aberdeen, United Kingdom
- +15 more
Jun 8, 2022
Diabetic Retinopathy, Dyslipidemias, Diabetes Trial (Fenofibrate, Placebo)
Completed
- Diabetic Retinopathy
- +2 more
- Fenofibrate
- Placebo
- (no location specified)
May 9, 2021
Huntington Disease Trial in Irvine (Fenofibrate, Placebo)
Active, not recruiting
- Huntington Disease
- Fenofibrate
- Placebo
-
Irvine, CaliforniaUniversity of California, Irvine
Apr 15, 2021
Dual Inhibition Lipid-lowering in Treatment of
Completed
- Dyslipidemia
- Ezetimibe 10 mg plus statin or ezetimibe 10 mg plus fenofibrate
- (no location specified)
Feb 7, 2022
Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Phenofibrate
- Placebo
-
Warsaw, Mazowieckie, Poland
- +1 more
Jun 8, 2023